Seeing Is Believing
KROS is currently covered by 5 analysts with an average price target of $26.85. This is a potential upside of $16.65 (163.24%) from yesterday's end of day stock price of $10.2.
Keros Therapeutics 's activity chart (see below) currently has 23 price targets and 39 ratings on display. The stock rating distribution of KROS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 35.82% with an average time for these price targets to be met of 24.86 days.
Highest price target for KROS is $47, Lowest price target is $15, average price target is $26.85.
Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 17-Jan-2025. First documented stock forecast 04-May-2020.
Currently out of the existing stock ratings of KROS, 24 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$4.14 (38.12%)
$105
26 days ago
(17-Jan-2025)
5/12 (41.67%)
$4.58 (43.95%)
43
Buy
$15
$4.14 (38.12%)
$63
26 days ago
(17-Jan-2025)
0/8 (0%)
$4.58 (43.95%)
Buy
$43
$32.14 (295.95%)
$100
1 months 20 days ago
(23-Dec-2024)
0/5 (0%)
$25.93 (151.90%)
Buy
$47
$36.14 (332.78%)
$100
1 months 30 days ago
(13-Dec-2024)
1/11 (9.09%)
$28.15 (149.34%)
113
Buy
$105
2 months ago
(12-Dec-2024)
0/2 (0%)
$53.23 (102.82%)
What is KROS (Keros Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on KROS (Keros Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on KROS (Keros Therapeutics )?
Which analyst is the currently most bullish on KROS (Keros Therapeutics )?
Which analyst is the currently most reserved on KROS (Keros Therapeutics )?